UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Parent-Reported Clinical Utility of Pediatric Genomic Sequencing

Pediatrics (Evanston), 2023-08, Vol.152 (2), p.1

2023

Volltextzugriff (PDF)

Economic evaluation of pediatric cancer treatment: a systematic literature review

Pediatrics (Evanston), 2013-01, Vol.131 (1), p.e273

2013

Volltextzugriff (PDF)

Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma

Pediatric hematology and oncology, 2017-07, Vol.34 (5), p.331-342

2017

Volltextzugriff (PDF)

Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters

Journal of patient-centered research and reviews, 2019-10, Vol.6 (4), p.243-251

2019

Volltextzugriff (PDF)

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

Molecular cancer therapeutics, 2009-08, Vol.8 (8), p.2461-2469

2009

Volltextzugriff (PDF)

The optimal timing of surgical resection in high-risk neuroblastoma

Journal of pediatric surgery, 2016-10, Vol.51 (10), p.1665-1669

2016

Volltextzugriff (PDF)

Blood product administration during high risk neuroblastoma therapy

Pediatric hematology and oncology, 2020-01, Vol.37 (1), p.5-14

2020

Volltextzugriff (PDF)

Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style

Pediatric blood & cancer, 2019-01, Vol.66 (1), p.e27497-n/a

Russell, Heidi V.

2019

Volltextzugriff (PDF)

Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma

Clinical cancer research, 2008-11, Vol.14 (21), p.7028-7034

2008

Volltextzugriff (PDF)

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Blood, 2011-12, Vol.118 (23), p.6050-6056

2011

Volltextzugriff (PDF)

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Nature medicine, 2008-11, Vol.14 (11), p.1264-1270

2008

Volltextzugriff (PDF)

Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature

Genetics in medicine, 2019-01, Vol.21 (1), p.3-16

2019

Volltextzugriff (PDF)

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

Journal of voice, 2024-04

2024

Volltextzugriff (PDF)

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study

Pediatric blood & cancer, 2011-08, Vol.57 (2), p.275-282

2011

Volltextzugriff (PDF)

Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations

Pediatric blood & cancer, 2019-07, Vol.66 (7), p.e27739-n/a

2019

Volltextzugriff (PDF)

Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group

Cancer, 2022-01, Vol.128 (2), p.317-325

2022

Volltextzugriff (PDF)

Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results

Genetics in medicine, 2020-01, Vol.22 (1), p.69-76

2020

Volltextzugriff (PDF)

Neuroblastoma of the Bone and Bone Marrow Without an Apparent Primary Site: Report of 4 Cases With Long-term Follow-up

Pediatric and developmental pathology, 2019-07, Vol.22 (4), p.329-333

2019

Volltextzugriff (PDF)

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

Genetics in medicine, 2022-01, Vol.24 (1), p.238-244

2022

Volltextzugriff (PDF)

Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions

Genetics in medicine, 2020-08, Vol.22 (8), p.1303-1310

2020

Volltextzugriff (PDF)

Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods

Genetics in medicine, 2022-10, Vol.24 (10), p.2014-2027

2022

Volltextzugriff (PDF)

Using decision modeling to guide drug allocation during a shortage

Pediatric blood & cancer, 2017-07, Vol.64 (7), p.n/a

2017

Volltextzugriff (PDF)

Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

World journal of gastroenterology : WJG, 2008-08, Vol.14 (30), p.4823-4825

2008

Volltextzugriff (PDF)

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Blood, 2005-03, Vol.105 (5), p.1898-1904

2005

Volltextzugriff (PDF)

Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors

Pediatric blood & cancer, 2020-10, Vol.67 (10), p.e28417-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Parent-Reported Clinical Utility of Pediatric Genomic Sequencing

Economic evaluation of pediatric cancer treatment: a systematic literature review

Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma

Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

The optimal timing of surgical resection in high-risk neuroblastoma

Blood product administration during high risk neuroblastoma therapy

Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style

Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study

Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations

Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group

Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results

Neuroblastoma of the Bone and Bone Marrow Without an Apparent Primary Site: Report of 4 Cases With Long-term Follow-up

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions

Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods

Using decision modeling to guide drug allocation during a shortage

Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors

Suchergebnisse filtern